Jonathan Lass is an Ophthalmology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 269 publications with 11,860 citations (h-index 48); ClinicalTrials.gov lists 6 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Avenue
Cleveland, OH 44106
Telephone
216-844-3601Provider last certified this registry record 10 Jan 2021.
Clinical trials
- Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years
Sponsor: Case Western Reserve University
- Impact of Donor Diabetes on DMEK Success and Endothelial Cell Loss
Sponsor: Case Western Reserve University
- Life 4°C Versus Optisol in Corneal Storage Media
Sponsor: University Hospitals Cleveland Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Oyster Point Pharma, Inc.Program year20232 payments
- Oyster Point Pharma, Inc.Program year20221 payment
- PFIZER INC.Program year20211 payment$19,172openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
65.9%Prostaglandin Analog65.9%Latanoprost100%Part D<11 patientsAnti-infectives
34.1%Tetracycline-class Drug34.1%Doxycycline Monohydrate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:
- Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Case Western Reserve University
FY2026$752,932UG1EY037206 - Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Case Western Reserve University
FY2026$450,364UG1EY037206 - Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes and Other Predictors on Corneal Transplant Endothelial Cell Loss and Success
Case Western Reserve University
FY2025$524,992UG1EY037206
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluation of Shared Genetic Susceptibility to High and Low Myopia and Hyperopia
JAMA Ophthalmology
2021 - Corneal Endothelial Cell Loss and Morphometric Changes 5 Years after Phacoemulsification with or without CyPass Micro-Stent
American Journal of Ophthalmology
2019 - Factors Associated With Graft Rejection in the Cornea Preservation Time Study
American Journal of Ophthalmology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Sophia Sundararajan, MD
University Hospitals of Cleveland
Sylvia Asa, MD, PhD
University Hospitals of Cleveland
Lloyd Greene, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”